Healthcare provider profile · identity verified

Walfrido Roque, APRN

Nurse Practitioner · HIALEAH, FL · NPI 1447746441

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1004	321
Rosuvastatin Calcium	Rosuvastatin Calcium	794	268
Albuterol Sulfate Hfa	Albuterol Sulfate	731	166
Metformin Hcl	Metformin Hcl	639	208
Gabapentin	Gabapentin	588	197
Lisinopril	Lisinopril	536	185
Losartan Potassium	Losartan Potassium	521	169
Omeprazole	Omeprazole	493	162
Pantoprazole Sodium	Pantoprazole Sodium	464	161
Amlodipine Besylate	Amlodipine Besylate	384	144
Levothyroxine Sodium	Levothyroxine Sodium	359	119
Metoprolol Succinate	Metoprolol Succinate	297	99
Glipizide	Glipizide	290	98
Hydrochlorothiazide	Hydrochlorothiazide	281	102
Montelukast Sodium	Montelukast Sodium	260	83
Alcohol Prep Pads	Alcohol Antiseptic Pads	242	81
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	231	71
Azithromycin	Azithromycin	226	179
Fluticasone Propionate	Fluticasone Propionate	214	86
Tamsulosin Hcl	Tamsulosin Hcl	206	73
Memantine Hcl	Memantine Hcl	205	66
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	199	81
Trazodone Hcl	Trazodone Hcl	191	63
Alendronate Sodium	Alendronate Sodium	190	54
Metoprolol Tartrate	Metoprolol Tartrate	188	71
Furosemide	Furosemide	183	64
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	179	40
Simvastatin	Simvastatin	179	61
Famotidine	Famotidine	166	60
Clopidogrel	Clopidogrel Bisulfate	157	55
Ciprofloxacin Hcl	Ciprofloxacin Hcl	151	117
Nabumetone	Nabumetone	145	112
Acarbose	Acarbose	138	43
Meclizine Hcl	Meclizine Hcl	130	51
Mirtazapine	Mirtazapine	129	49
Carvedilol	Carvedilol	125	43
Ibuprofen	Ibuprofen	122	77
Escitalopram Oxalate	Escitalopram Oxalate	113	42
Chlorthalidone	Chlorthalidone	110	33
Latanoprost	Latanoprost	110	23
Alcohol Swabs	Alcohol Antiseptic Pads	100	36
Enalapril Maleate	Enalapril Maleate	100	33
Diclofenac Sodium	Diclofenac Sodium	99	59
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	97	27
Eliquis	Apixaban	96	42
Irbesartan	Irbesartan	96	32
Donepezil Hcl	Donepezil Hcl	85	26
Dexamethasone	Dexamethasone	83	72
Comfort Ez Pen Needle	Pen Needle, Diabetic	81	27
Baclofen	Baclofen	79	49
Ammonium Lactate	Ammonium Lactate	78	41
Mupirocin	Mupirocin	76	54
Ketoconazole	Ketoconazole	75	32
Meloxicam	Meloxicam	74	57
Atenolol	Atenolol	70	27
Sertraline Hcl	Sertraline Hcl	66	28
Nifedipine Er	Nifedipine	64	21
Ciclopirox	Ciclopirox	60	25
Metronidazole	Metronidazole	60	49
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	53
Clobetasol Propionate	Clobetasol Propionate	55	20
Methocarbamol	Methocarbamol	54	28
Azelastine Hcl	Azelastine Hcl	53	19
Januvia	Sitagliptin Phosphate	52	18
Dicyclomine Hcl	Dicyclomine Hcl	50	19
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	50	17
Glipizide Er	Glipizide	49	18
Sucralfate	Sucralfate	49	18
Farxiga	Dapagliflozin Propanediol	47	12
Xarelto	Rivaroxaban	47	12
Allopurinol	Allopurinol	46	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	44	14
Insulin Lispro Kwikpen U-100	Insulin Lispro	44	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	16
Citalopram Hbr	Citalopram Hydrobromide	43	14
Enulose	Lactulose	43	21
Oxybutynin Chloride	Oxybutynin Chloride	43	12
Spironolactone	Spironolactone	42	15
Ventolin Hfa	Albuterol Sulfate	42	suppressed
Methylprednisolone	Methylprednisolone	40	33
Quetiapine Fumarate	Quetiapine Fumarate	40	14
Vitamin D2	Ergocalciferol (Vitamin D2)	38	24
Triamcinolone Acetonide	Triamcinolone Acetonide	37	13
Hydralazine Hcl	Hydralazine Hcl	36	13
Symbicort	Budesonide/Formoterol Fumarate	36	suppressed
Finasteride	Finasteride	34	15
Glimepiride	Glimepiride	34	14
Ondansetron Hcl	Ondansetron Hcl	34	25
Cilostazol	Cilostazol	33	suppressed
Clonazepam	Clonazepam	32	16
Myrbetriq	Mirabegron	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	16
Valsartan	Valsartan	32	15
Fenofibrate	Fenofibrate	31	suppressed
Humalog Kwikpen U-100	Insulin Lispro	31	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	31	suppressed
Tradjenta	Linagliptin	31	11
Duloxetine Hcl	Duloxetine Hcl	30	12
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Hydrocortisone	Hydrocortisone	29	16
Olmesartan Medoxomil	Olmesartan Medoxomil	28	12
Glipizide-Metformin	Glipizide/Metformin Hcl	27	suppressed
Prednisone	Prednisone	27	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Temazepam	Temazepam	26	13
Bumetanide	Bumetanide	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	22
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	11
Jardiance	Empagliflozin	24	suppressed
Trifluoperazine Hcl	Trifluoperazine Hcl	24	suppressed
Acyclovir	Acyclovir	23	17
Comfort Ez Insulin Syringe	Syringe And Needle,insulin,1ml	23	suppressed
Timolol Maleate	Timolol Maleate	23	suppressed
Alprazolam	Alprazolam	22	16
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Naproxen	Naproxen	22	15
Entresto	Sacubitril/Valsartan	21	suppressed
Erythromycin	Erythromycin Base	21	14
Linzess	Linaclotide	21	suppressed
Droplet Micron Pen Needle	Pen Needle, Diabetic	20	11
Ezetimibe	Ezetimibe	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Ciclopirox	Ciclopirox Olamine	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	16	12
Lactulose	Lactulose	16	13
Levofloxacin	Levofloxacin	16	15
Sulindac	Sulindac	16	13
Unifine Pentips	Pen Needle, Diabetic	16	suppressed
Cephalexin	Cephalexin	15	15
Labetalol Hcl	Labetalol Hcl	15	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	15	14
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Repaglinide	Repaglinide	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Cefdinir	Cefdinir	14	14
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Nystatin	Nystatin	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Lumigan	Bimatoprost	13	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	12	suppressed
Dexilant	Dexlansoprazole	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Methimazole	Methimazole	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Permethrin	Permethrin	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	11	suppressed
Synjardy	Empagliflozin/Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error